SCHEMBL6072050

SCHEMBL6072050

CCOc1cc2c(c3c1OC(C)(C)C3)C(c1ccc(C(=O)O)c(NCc3ccccc3OC)c1)=NC(C)(C)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.42
ASPH Q12797 1/20 0.42
KDM8 Q8N371 1/20 0.42
TSHR P16473 1/20 0.38
MAPT P10636 5/20 0.37
LMNA P02545 4/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
IDO1 P14902 1/20 0.36
TP53 P04637 2/20 0.35
GAA P10253 2/20 0.35
HSD17B10 Q99714 2/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ACP1 P24666 1/20 0.34
KMT2A Q03164 1/20 0.34
EDNRB P24530 2/20 0.34
USP2 O75604 1/20 0.34
SSTR5 P35346 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6071964 0.94 TSHR (0.38) KDM4EASPHKDM8TSHRMAPT
SCHEMBL6072191 0.90 ACLY (0.38) KDM4EASPHKDM8MAPTLMNA
SCHEMBL6072844 0.89 ACLY (0.41) KDM4ETSHRMAPTLMNAALDH1A1
SCHEMBL6072672 0.89 NPSR1 (0.40) KDM4ETSHRMAPTLMNAALDH1A1
SCHEMBL6072299 0.88 PKM (0.36) KDM4EMAPTLMNAALDH1A1HPGD
SCHEMBL6072284 0.88 IDO1 (0.33) KDM4ETSHRMAPTLMNAALDH1A1
SCHEMBL6072061 0.88 KDM4E (0.40) KDM4EASPHKDM8TSHRALDH1A1
SCHEMBL6072777 0.87 AKR1C3 (0.35) KDM4ETSHRMAPTLMNAALDH1A1
SCHEMBL6072762 0.86 IDO1 (0.32) KDM4EMAPTLMNAALDH1A1IDO1
SCHEMBL6071890 0.86 POLB (0.36) KDM4EMAPTLMNAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060106048-A1 Furoisoquinoline derivative and use thereof PASCALI, PETROS P. (CY) 2006-05-18 US disclosed
EP-1541576-A1 FUROISOQUINOLINE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106048-A1 Furoisoquinoline derivative and use thereof PDE3B, PDE2A, PDE3A KDM4E 358/4885ASPH 778/4885KDM8 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.